OBJECTIVES: Surgical ablation is an option for patients with atrial fibrillation (AF) undergoing concomitant cardiac surgery. This study aims to evaluate the outcome of surgical ablation during concomitant cardiac surgery and to identify the independent predictors for a primary end-point consisting of AF or atrial flutter (AFL) recurrence, death, permanent pacemaker implantation and necessity for antiarrhythmic drugs and the effects of reintervention for AF/AFL recurrence.
INTRODUCTION
Atrial fibrillation (AF) is the most common supraventricular arrhythmia. It negatively affects haemodynamic and cardiac function and may lead to transient ischaemic attack, stroke and peripheral artery embolism. For patients with obstructive coronary artery disease or significant valvular heart disease, the incidence of AF is significantly increased. Ventricular remoulding by AF can also complicate existing cardiac disease. Therefore, surgical ablation concomitant to other required cardiac surgery may improve the prognosis of a patient with AF. The traditional cutand-sew maze III procedure was introduced in 1987 by James L. Cox and still represents the gold standard for surgical treatment of AF [1] . In the 21st century, ablation tools have replaced the traditional cut-and-sew technique, which have simplified and shortened the maze procedure dramatically [2] [3] [4] [5] .
METHODS
From October 2004 to April 2015, 1028 consecutive patients with persistent AF (defined according to the 2012 HRS/EHRA/ ECAS Expert Consensus [6] ) underwent surgical ablation concomitant to other cardiac surgery in our institute. Nine hundred and twenty-seven patients were followed up and divided into 2 groups: patients who reached the primary end-point (PE) and patients who maintained sinus rhythm (SR) at follow-up. Table 1 presents baseline data including demographic characteristics, transthoracic echocardiography (TTE) and 24-h Holter results. 
GENERAL ADULT CARDIAC
Surgical technique 
Medication strategy
Anti-arrhythmic drugs (AADs) were administered to all patients after surgery for at least 3 months unless contraindicated. Amiodarone was the first choice. If the patients exhibited SR at 3 months, the use of AADs was discontinued. Warfarin was administrated with a target international normalized ratio of 1.8-2.5 in the first 3 months and thereafter if mechanical valves were implanted or AF/atrial flutter (AFL) recurred. Warfarin was not necessary for patients without mechanical valves implanted and for patients who were AF/AFL free at 3 months. For those who had no mechanical valves implanted but did have AF/AFL at 3 months or later, warfarin was administrated if the risk assessed by CHA 2 DS 2 -VASc score and other characteristics was high. The treating cardiologists determined the medication treatment strategy.
Follow-up and primary end-point definition
Electrocardiography and TTE were obtained before discharge. The first 3 months was defined as the 'blanking period', and therefore, early recurrence of AF/AFL within the first 3 months was not evaluated [6] . Patients were followed up with 24-h Holter and TTE at 3, 6 and 12 months postoperatively and annually thereafter. Medications, complications and cardiac function classification [based on the New York Heart Association (NYHA)] were also recorded at each follow-up. The PE was a composite of all-cause mortality, recurrence of AF or AFL, implantation of a permanent pacemaker and use of AADs. Reaching the PE meant ablation failure. In this study, AADs were defined as either Vaughan-Williams Type I or III AADs, but betablockers or calcium channel blockers were not considered AADs.
Reintervention
Several patients with AF/AFL recurrence received reintervention, including synchronized electrical cardioversion, pharmacological cardioversion, radio frequency catheter ablation (RFCA) and cryoablation by the cardiologists in the same institute.
Data analysis
Patients who underwent follow-up were divided into 2 groups, the PE group or the SR group. To analyse the variables in baseline characteristics and perioperative outcomes, the distributions of categorical variables between the 2 groups were examined with the log-rank test, and the differences of continuous variables were calculated by univariable Cox regression analysis. Freedom from PE and freedom from AF/AFL after reintervention was calculated and plotted by Kaplan-Meier analysis.
Cox proportional hazards regression analysis was used to examine the association between the PE and related predictors. The proportional hazards assumption was evaluated by including timedependent coefficients into the regression model, and there were no violations of this assumption. All variables with P < 0.1 by prior univariate analysis were entered into the multivariable Cox regression model, hazard ratios (HRs) and 95% confidence interval (CI) were reported. Statistical significance was present when P < 0.05.
The distribution of TTE parameters and NYHA class were examined by Kolmogorov-Smirnov Z test, followed by Wilcoxon signed-rank test to evaluate whether these variables improved at the latest follow-up compared with preoperative data. The difference of each variable between follow-up and preoperation was calculated, Mann-Whitney U-test was used to analyse whether there was significance between PE group and SR group.
All statistical analyses were analysed using IBM SPSS Statistics for Windows, Version 21.0 (Released 2012, IBM Corporation, Armonk, NY, USA) and GraphPad Prism, Version 6.00 for Windows (GraphPad Software, La Jolla, CA, USA, www.graphpad.com).
RESULTS

Patient characteristics and perioperative outcomes
This cohort consisted of 1028 patients, with a mean age of 52.3 ± 10.5 years. Eight hundred and sixty-three patients (83.9%) were diagnosed with rheumatic heart disease (RHD). The mean preoperative AF duration was 75.2 ± 97.2 months (range: 1-576 months). Concomitant valve surgeries were performed in 1003 patients (97.6%). Other patient characteristics are listed in Table 1 .
The overall operative mortality was 1.1% (11 of 1028). The major causes of death were low cardiac output syndrome, pulmonary infection and multiple organ dysfunction syndrome. Forty-three patients (4.2%) required reoperation for bleeding. Four patients (0.4%) had a permanent pacemaker implanted due to third-degree atrioventricular block. Other major complications included early strokes (14 patients, 1.4%), low cardiac output syndrome requiring intra-aortic balloon pump support (15 patients, 1.5%), pulmonary infection (44 patients, 4.3%) and acute renal dysfunction requiring haemodialysis (13 patients, 1.3%). Six hundred and ninety-seven (68.5%) patients returned to SR at discharge, and AF or AFL were documented in 320 (31.5%) patients.
Follow-up result
Follow-up was performed, and the data were available for 927 of 1017 (91.2%) discharged patients. Ninety patients were lost to or rejected follow-up. The mean follow-up length was 29.0 ± 22.7 months. Five hundred and eighty patients (62.6%) stayed in SR with or without AADs at the latest follow-up, and 542 (58.5%) were AADs free. Three hundred and eighty-five patients reached the PE. Ten patients (1.1%) died during follow-up, 206 (22.2%) had AF and 128 (13.8%) had AFL recurrence, 3 (0.3%) patients required permanent pacemaker implantation due to third-degree AV block or sick sinus syndrome (SSS). Thirty-eight (4.1%) patients were taking AADs to maintain SR. The overall rate of PE free at 1, 2 and 3 years was 86.8, 79.4 and 68.3%, respectively (Fig. 1) .
Additionally, 18 patients (1.9%) had transient ischaemia attack or stroke. Seven hundred and nine patients (76.5%) were on warfarin, with an international normalized ratio range from 1.8 to 2.5. Of these, 328 patients reached the PE. Three hundred and eighty-one patients maintained SR and were free from AADs, but with mechanical valves implanted. Anticoagulant-related bleeding was reported in 59 (6.4%) cases.
Predictors for primary end-point
Patients were divided into 2 groups, the PE group and the SR group, according to the follow-up status. Age, gender, AF classification, hypertension, diabetes, smoking, rheumatic heart disease, degenerative valvular disease, preoperative RA diameters, mitral valve surgeries, tricuspid valve surgeries, prosthetic valve type and heart rhythm at discharge were identified as possible predictors for reaching PE in perioperative variables using univariate time-to-event analysis between the 2 groups. Then the Cox proportional hazards regression was conducted, and hypertension (HR: 1.710, 95% CI: 1.211-2.415), diabetes (HR: 1.624, 95% CI: 1.048-2.517, smoking (HR: 1.764, 95% CI: 1.168-2.665), preoperative RA diameter (HR: 1.019, 95% CI: 1.008-1.030) and AF/ AFL at discharge (HR: 2.610, 95% CI: 2.070-3.291) were identified as independent predictors of increased hazard of the event (Table 2) .
Cardiac function evaluation
Cardiac function was evaluated by both the NYHA classification and the TTE parameters. For the overall 927 patients and patients who stayed in SR off AADs at latest follow-up, the NYHA class and ejection fraction improved, and the transverse diameter of LA, RA and left ventricular diastolic diameter decreased significantly at latest follow-up compared with the corresponding preoperative data (Table 3) . SR group had better improvement of NYHA class, EF and left ventricular diastolic diameter than PE group (Table 4) .
Reintervention
Reintervention was conducted in 63 patients after reaching the PE. Sixty patients underwent cardioversion treatment due to AF or AFL recurrence (Table 5 ). Three patients who developed sick sinus syndrome or third-degree AV block received permanent pacemaker implantation. Follow-up after PE was available to all reintervened patients. The mean follow-up duration was 23.0 ± 2 3.3 months. The freedom from AF/AFL rate at 12, 24 and 36 months after intervention was 84.0, 77.1 and 73.6%, respectively, with or without AADs, and 78.3, 62.8 and 49.9%, respectively, off AADs (Fig. 2) .
DISCUSSION
The electrophysiological mechanism may vary in different types of AF. Focal triggers in the atrium likely initiate most paroxysmal AF and 90% of which located surrounding the orifices of the pulmonary veins. About 10% of focal triggers can be identified in the RA, crista terminalis or left atrial appendage [7, 8] . Therefore, PV isolation using different energy sources might yield satisfactory results for paroxysmal AF. As the duration of AF increases, one or more large macro-re-entrant circuits may develop in the atrium due to the atrial remodelling and atrial fibrosis, thus, paroxysmal AF begins to convert to persistent AF. The circuits can involve the left atrial appendage, mitral isthmus, coronary sinus, tricuspid isthmus and other components [3] . Hence, simple isolation of the PVs may not be sufficient to break the re-entrant circuits in persistent AF. In 1987, James Cox introduced the maze III procedure [1] , which has become the gold standard for surgical treatment of AF [5, 9] . In the 21st century, the maze IV procedure consists of a new lesion set plus new energy sources like radio frequency and cryotherapy has replaced the traditional 'cut-and-sew' technique. The maze IV procedure has shorter operation times and presents fewer complications and reasonable results [3, 10] . The primary concomitant cardiac disease in the subjects in our study is RHD. The incidence of acute rheumatic fever and the prevalence of RHD have decreased since the 1950s, but the prevalence of RHD in China (186 of 100 000 adults) remains more than 10 times higher than in developed countries such as Canada (0.22 of 1000) and Japan (0.14 of 1000) [11] . The incidence of AF may be up to 40% in RHD patients [12] . Since RHD remains the primary aetiology for valve surgeries in China, the number of RHD with AF patients who underwent valve surgery plus surgical ablation for AF may be higher than that in developed countries.
AF may be a risk factor for cardiac surgeries. Several studies have reported that patients with AF undergoing aortic valve replacement and mitral surgery or coronary artery bypass grafting exhibit increased long-term morbidity and mortality [13] [14] [15] [16] . Thus, AF may be an independent risk factor for both in-hospital and long-term morbidity and mortality. Surgical ablation during concomitant cardiac surgery may improve the prognosis of patients with AF. Our study demonstrates that patients who maintained SR had better NYHA, EF and decreased size of LA and RA compared to patients who reached the PE, which suggests that successful ablation could improve cardiac function in concomitant cardiac patients with AF preoperatively. Recent guidelines for AF management recommend surgical ablation for patients with AF undergoing cardiac surgery for other indications, especially for those who are symptomatic [6, 17] .
In this study, the freedom from AF/AFL, death or permanent pacemaker implantation off AADs was 86. 8 that freedom from AF was 89% at 12 months in a group of 282 patients who underwent a concomitant maze IV procedure. In a recent study, Ad et al. [18] reported that the SR rate was 85% (71% off AADs) at 5 years in 787 patients. In our centre, modified RA ablation lesions (only tricuspid isthmus lesion) were adopted and coronary sinus enhancement ablation was absent in the early years (Table 1) , which may explain the differences between our result and the existing studies. However, our analysis showed no difference in the PE group or the SR group for the standard maze IV procedure including enhanced ablation by monopolar pen on coronary sinus and RA lesions including SVC-IVC line, incisionright atrial appendage line. However, this may be explained because the sample size was not large enough (n = 133). But we thought standard maze IV procedure may improve the long-term results. However, this requires further study. Previous studies have suggested that age, atrial diameter, duration of AF, AF classification, postoperative atrial tachycardia and higher EuroSCORE are predictors for AF recurrence after ablation [2, [19] [20] [21] [22] . In our study, early postoperative AF or AFL, preoperative RA diameter, hypertension, diabetes and smoking are the predictors of the PE. The amount of multiple wavelets may increase and the location of recurrent circuits may be different in the large atrium, which could lead to ablation failure. Additionally, the lesions may not be transmural or continuous in larger atrium. Early postoperative AF or AFL may be a result of myocardial oedema or inflammation, but it would indicate the existence of the gaps or failure of transmural ablation [23] .
AFL recurred in 128 (13.8%) patients, of whom 34 had a reintervention by RFCA. Three-dimensional electroanatomic mapping revealed that 19 AFL cases originated in the LA, 7 in both the LA and the RA and 12 in the RA. The recurrent circuits in these patients were mainly located in the mitral isthmus, the ends of the box line for PV isolation, or in the IVC-tricuspid zone. In some patients, especially those who received box lesions in the LA, the wavefronts of SR could be interrupted by the box line, thus producing a new macro circuit through the mitral isthmus (atypical LA-originated AFL). The coronary sinus is electrically conductive as is the atrial muscle. Ablation of the coronary sinus in addition to ablation of the mitral isthmus is essential for mitral isthmus electrical isolation. This was not accomplished in all our patients, thus leading to failure of the ablation line set. To achieve this goal, we suggest the combined use of the bipolar ablation clamp and the monopolar ablation pen together to ablate the mitral isthmus and coronary sinus or to primarily utilize surgical cryotherapy to ablate the coronary sinus.
In our study, only 16.1% (60 of 372) patients with AF/AFL recurrence underwent reintervention, including synchronized electrical cardioversion, pharmacological cardioversion, RFCA and catheter cryoablation. Many recurrent patients could not have a reintervention due to financial constraints. The overall freedom from AF/AFL after reintervention at 12, 24 and 36 months was 86.4, 76.9 and 73.4%, respectively, with or without AADs, while it was 82.0, 65.7 and 52.3%, respectively, off AADs, suggesting reintervention could be beneficial regardless of financial cost. RFCA and catheter cryoablation may be more effective options than synchronized electrical cardioversion or pharmacological cardioversion, but further study is required to confirm this hypothesis.
CONCLUSION
In our study, surgical ablation has a high success rate and may improve cardiac function postoperatively. Early stage atrial arrhythmia, large RA size, hypertension, diabetes and smoking are the major independent predictors for reaching the PE. For those who suffered from AF/AFL recurrence, cardioversion and/ or catheter ablation can achieve a favourable clinical outcome.
